CONTRAVE is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Naltrexone Hydrochloride; Bupropion Hydrochloride.
Product ID | 50090-2868_c5a82f8e-c627-4d42-8046-47c94ed56884 |
NDC | 50090-2868 |
Product Type | Human Prescription Drug |
Proprietary Name | CONTRAVE |
Generic Name | Naltrexone Hydrochloride And Bupropion Hydrochloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2014-09-10 |
Marketing Category | NDA / NDA |
Application Number | NDA200063 |
Labeler Name | A-S Medication Solutions |
Substance Name | NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE |
Active Ingredient Strength | 8 mg/1; mg/1 |
Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2017-02-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA200063 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-02-15 |
Marketing End Date | 2018-09-30 |
Ingredient | Strength |
---|---|
NALTREXONE HYDROCHLORIDE | 8 mg/1 |
SPL SET ID: | f074eeef-312c-4e7d-869d-79c24e0c514e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
43063-772 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
50090-2868 | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride |
50090-2945 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
51267-890 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
64764-890 | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CONTRAVE 86026234 5181874 Live/Registered |
Orexigen Therapeutics, Inc. 2013-08-01 |
CONTRAVE 78979619 3393576 Live/Registered |
NALPROPION PHARMACEUTICALS LLC 2006-01-06 |
CONTRAVE 78794374 not registered Dead/Abandoned |
AGrow Tech LLC 2006-01-18 |
CONTRAVE 78786858 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2006-01-06 |
CONTRAVE 77926232 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2010-02-02 |
CONTRAVE 77925784 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2010-02-02 |
CONTRAVE 77811077 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2009-08-24 |